Effect of high-flow nasal therapy on dyspnea, comfort, and respiratory rate
- PMID: 31167660
- PMCID: PMC6549315
- DOI: 10.1186/s13054-019-2473-y
Effect of high-flow nasal therapy on dyspnea, comfort, and respiratory rate
Conflict of interest statement
Cesare Gregoretti received fees for consultancies or lectures from Orion Pharma, ResMed, Medtronic, Philips, Air Liquide and EOVE, and travel cost reimbursement from Fisher & Paykel. All other authors declared that they have no competing interests.
References
-
- Cortegiani A, Crimi C, Sanfilippo F, Noto A, Di Falco D, Grasselli G, Gregoretti C, Giarratano A. High flow nasal therapy in immunocompromised patients with acute respiratory failure: a systematic review and meta-analysis. J Crit Care. 2019;50:250–256. doi: 10.1016/j.jcrc.2018.12.015. - DOI - PubMed
-
- Rochwerg B., Granton D., Wang D. X., Helviz Y., Einav S., Frat J. P., Mekontso-Dessap A., Schreiber A., Azoulay E., Mercat A., Demoule A., Lemiale V., Pesenti A., Riviello E. D., Mauri T., Mancebo J., Brochard L., Burns K. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Medicine. 2019;45(5):563–572. doi: 10.1007/s00134-019-05590-5. - DOI - PubMed
-
- Spoletini G, Cortegiani A, Gregoretti C. Physiopathological rationale of using high-flow nasal therapy in the acute and chronic setting: a narrative review. Trends Anaesth Crit Care. 2019. 10.1016/j.tacc.2019.02.001.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical